Functional haplotypes that produce normal ficolin-2 levels protect against clinical leprosy

Journal of Infectious Diseases

Volumn 199, Issue 6, 2009, Pages 801-804

  De Messias Reason, Iara ^a,b,c   Kremsner, Peter G ^a   Kun, Jürgen F J ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Immunopathology Laboratory   (Brazil)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FICOLIN; FICOLIN 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAZIL; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENETIC CODE; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; LEPROSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

CHROMOSOME MAPPING; DNA PRIMERS; EXONS; GENES, DOMINANT; GENES, RECESSIVE; HAPLOTYPES; HUMANS; LECTINS; LEPROSY; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; REFERENCE VALUES;

EID: 65749105631     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/597070     Document Type: Article

References (15)

1. Britton WJ, Lockwood DN. Leprosy. Lancet 2004; 363:1209-19.
2. Alter A, Alcais A, Abel L, Schurr E. Leprosy as a genetic model for susceptibility to common infectious diseases. Hum Genet 2008; 123:227-35.
3. de Messias-Reason IJ, Boldt AB, Moraes Braga AC, et al. The association between mannan-binding lectin gene polymorphism and clinical leprosy: new insight into an old paradigm. J Infect Dis 2007; 196:1379-85.
4. Krarup A, Thiel S, Hansen A, Fujita T, Jensenius JC. L-ficolin is a pattern recognition molecule specific for acetyl groups. J Biol Chem 2004; 279: 47513-9.
5. Hummelshoj T, Munthe-Fog L, Madsen HO, Fujita T, Matsushita M, Garred P. Polymorphisms in the FCN2 gene determine serum variation and function of ficolin-2. Hum Mol Genet 2005; 14:1651-8.
6. Hummelshoj T, Thielens NM, Madsen HO, Arlaud GJ, Sim RB, Garred P. Molecular organization of human ficolin-2. Mol Immunol 2007; 44: 401-11.
7. Hummelshoj T, Munthe-Fog L, Madsen HO, Garred P. Functional SNPs in the human ficolin (FCN) genes reveal distinct geographical patterns. Mol Immunol 2008; 45:2508-20.
8. Atkinson AP, Cedzynski M, Szemraj J, et al. L-ficolin in children with recurrent respiratory infections. Clin Exp Immunol 2004; 138:517-20.
9. Roos A, Rastaldi MP, Calvaresi N, et al. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 2006; 17:1724-34.
10. Dornelles LN, Pereira-Ferrari L, Messias-Reason I. Mannan-binding lectin plasma levels in leprosy: deficiency confers protection against the lepromatous but not the tuberculoid forms. Clin Exp Immunol 2006; 145:463-8.
11. Ridley DS, Jopling WH. Classification of leprosy according to immunity: a five-group system. Int J Lepr Other Mycobact Dis 1966; 34:255-73.
12. Hansen G. Investigations concerning the etiology of leprosy [in Norwegian]. Norsk Mag Laegervidenskaben 1874; 4:1-88.
13. Mira MT. Genetic host resistance and susceptibility to leprosy. Microbes Infect 2006; 8:1124-31.
14. Chen X, Katoh Y, Nakamura K, et al. Single nucleotide polymorphisms of ficolin 2 gene in Behcet's disease. J Dermatol Sci 2006; 43:201-5.
15. Chapman SJ, Vannberg FO, Khor CC, et al. Functional polymorphisms in the FCN2 gene are not associated with invasive pneumococcal disease. Mol Immunol 2007; 44:3267-70.